GH - Guardant Health Non-GAAP EPS of -$0.82 beats by $0.11 revenue of $137.2M beats by $7.78M
2023-08-03 16:17:40 ET
- Guardant Health press release ( NASDAQ: GH ): Q2 Non-GAAP EPS of -$0.82 beats by $0.11 .
- Revenue of $137.2M (+25.8% Y/Y) beats by $7.78M .
- Guardant Health now expects full year 2023 revenue to be in the range of $545 to $550 million, vs. consensus of $540.98M, representing growth of 21% to 22% compared to full year 2022. This compares to its previous guidance range of $535 to $545 million.
- Guardant Health continues to expect full year 2023 operating expenses to be below full year 2022, driven by efficiency measures and continued leverage of its existing infrastructure, and free cash flow to be approximately negative $350 million in 2023.
For further details see:
Guardant Health Non-GAAP EPS of -$0.82 beats by $0.11, revenue of $137.2M beats by $7.78M